41

DAFTAR PUSTAKA

1 In: Sulistia Gan Gunawan (eds.) Farmakologi dan Terapi, 5th ed. Jakarta:

FK Universitas Indonesia; 2008. p230-246

2 Toms L, McQuay HJ, Derry S, Moore RA. Single Dose Oral Paracetamol

(Acetaminophen) For Postoperative Pain in Adults. The Cochrane

Collaboration. 20012;(6)

3 Adnan Asaad Abu omar, Khaled Awwad Al issa. Intravenous

paracetamol (Prefalgan) for analgesia after cesarean section. Rawal

Medical Journal.2011;36(4)

4 J. A. Alhashemi and M. F. Daghistani. Effects of intraoperative i.v

acetaminophen vs i.m meperidine on post-tonsillectomy pain in children.

British Journal of Anaesthesia.2006;(6)

5 Heirmayani. Toksikopatologi Hati Mencit Pada Pemberian Parasetamol.

IPB. 2007

6 Paramita, P. Kadar Serum Aspartat Aminotransferase dan Alanin

Aminotransferase Pada Tikus Wistar Setelah Pemberian Asetaminofen

Per Oral Dalam Berbagai Dosis. Semarang: UNDIP. 2007

7 Moynihan, R. FDA fails to reduce accessibility of paracetamol despite

450 deaths a year. BMJ; 2002. p325-678

8 Siker BPOM. Data keracunan parasetamol di Indonesia tahun 2002-

2005.BPOM. 2006

9 Soenarjo (eds.). Anestesiologi. Semarang: IDSAI Cabang Jawa Tengah.

2002; p295-309
 42

10 Sherlock, S. Penyakit Hati dan Sistem Saluran Empedu. Jakarta: Widya

Medika. 1995;p145-167

11 Departemen Pendidikan Nasional. Kamus Besar Bahasa Indonesia

[internet]. [cited 2013 februari 9]. Available from:

http://bahasa.kemdiknas.go.id/kbbi/index.php Susilaningsih,

12 Boulton, T.B. Anestesiologi, Edisi 10. Jakarta: EGC. 2004;p120-122

13 Latief, S.A. et al. Petunjuk Praktis Anestesiologi. Jakarta: Bag.

Anestesiologi dan Terapi intensif FK UI. 2002;p86-90

14 Katzung, B.G. Farmakologi Dasar dan Klinik. Jakarta: Salemba Medika.

2004;p479-489

15 Dorland. Kamus Kedokteran Dorland. Jakarta: EGC. 2008;p.(n)

16 Price, S.A et al. Patofisiologi vol. 1. Jakarta: EGC. 2005;p457-515

17 Bagian Anatomi. Situs Abdominis. Semarang: Bagian Anatomi, Fakultas

Kedokteran Universitas Diponegoro

18 Leeson S.T. et al. Buku Ajar Histologi. Jakarta: EGC. 2003

19 Neni. Lecture Notes Histologi 2. Semarang: Bagian Histologi Fakultas

Kedokteran UNDIP. 2010

20 Aru W dkk. Ilmu Penyakit Dalam Jilid 1 Edisi V. Jakarta:

InternaPublishing. 2009;p640-688

21 Marshall, W. Alanine Aminotranferase (Serum, Plasma). The Association

for Clinical Biochemistry. 2012

22 Guyton and Hall. Textbook Of Medical Physiology. Jakarta:EGC.1997;

23 Girindra A. Patologi Klinik. Bogor:IPB. 1986

 43

24 Frank C. Toksikologi Dasar, Edisi 2. Jakarta: Balai Penerbit FK UI.

1995;p111-113

25 Julita, I. Aspek Farmakokinetik Klinik Beberapa Obat Berpotensi

Hepatotoksik Pada Pasien Rawat Inap di Bangsal Paru RSUP Dr. M.

Djamil Padang.2011

26 World Health Organization (WHO). General Guidelines for

Methodologies on Research and Evaluation of Traditional Medicine.

Geneva: WHO. 2000

27 Laurence, D.R. et al. Evaluation of Drug Activities. London: Academic

Press.1964

28 LeeWM, Ostapowicz G. Acetaminophen : Pathology and

clinicalpresentations of hepatotoxicity. In: Kaplowitz N, DeLeve LD,

editors. DrugInduced Liver Injury. Informa Healthcare USA, 2007

29 Nelson SD, Bruschi SA. Mechanisms of acetaminophen induced

liverdamage. In: Kaplowitz N, DeLeve LD, editors. Drug Induced Liver

Injury.Informa Healthcare USA, 2007

30 MedlinePlus [internet]. United State: SGPT/ALT; 2011 [update 2013 Feb

2; cited 2013 Jul 31]. Available from: http://www.webmd.com/digestive-

disorders/alanine-aminotransferase-alt?page=2

31 E, Kosasih dan A.S Kosasih. Tafsiran hasil pemeriksaan laboratorium

klinik, Edisi 2. Tangerang: Karishma Publishing Group; 2008;p150-152

LAMPIRAN
 44

LAMPIRAN 1. ETHICAL CLEARANCE

LAMPIRAN 2. SURAT IJIN PENELITIAN

 45

LAMPIRAN 3. HASIL PENELITIAN

 46

Case Processing Summary

Cases
pemberian Valid Missing Total
parasetamol N Percent N Percent N Percent
kadar KONTROL 5 100.0% 0 .0% 5 100.0%
SGPT PERLAKUAN 1 5 100.0% 0 .0% 5 100.0%
PERLAKUAN 2 5 100.0% 0 .0% 5 100.0%
Descriptives

pemberian
parasetamol Statistic Std. Error
kadar KONTROL Mean 67.780 3.1080
SGPT 95% Confidence Lower Bound 59.151
Interval for Mean Upper Bound
76.409

5% Trimmed Mean 67.794

Median 68.500
Variance 48.297
Std. Deviation 6.9496
Minimum 59.7
Maximum 75.6
Range 15.9
Interquartile Range 13.7
Skewness -.117 .913
Kurtosis -2.529 2.000
PERLAKUAN 1 Mean 90.540 7.3971
95% Confidence Lower Bound 70.002
Interval for Mean Upper Bound
111.078

5% Trimmed Mean 90.544

Median 95.700
Variance 273.588
Std. Deviation 16.5405
Minimum 71.5
Maximum 109.5

Range 38.0
Interquartile Range 31.9
 47

Skewness -.232 .913

Kurtosis -2.494 2.000
PERLAKUAN 2 Mean 98.560 9.2999
95% Confidence Lower Bound 72.739
Interval for Mean Upper Bound
124.381

5% Trimmed Mean 99.644

Median 107.700
Variance 432.443
Std. Deviation 20.7953
Minimum 63.2
Maximum 114.4
Range 51.2
Interquartile Range 32.4
Skewness -1.750 .913
Kurtosis 3.053 2.000

Tests of Normality

Kolmogorov-Smirnov(a) Shapiro-Wilk
pemberian
parasetamol Statistic df Sig. Statistic df Sig.
kadar KONTROL .205 5 .200(*) .922 5 .540
SGPT PERLAKUAN 1 .225 5 .200(*) .906 5 .442
PERLAKUAN 2 .270 5 .200(*) .804 5 .087
* This is a lower bound of the true significance.
a Lilliefors Significance Correction

120.0

100.0
kadar SGPT

80.0

11
60.0

KONTROL PERLAKUAN 1 PERLAKUAN 2

pemberian parasetamol
 48

Test of Homogeneity of Variances

kadar SGPT
Levene
Statistic df1 df2 Sig.
1.850 2 12 .199

ANOVA

kadar SGPT
Sum of
Squares df Mean Square F Sig.
Between Groups 2549.577 2 1274.789 5.070 .025
Within Groups 3017.312 12 251.443
Total 5566.889 14

Post Hoc Tests

Multiple Comparisons

Dependent Variable: kadar SGPT

LSD
Mean
(I) pemberian (J) pemberian Difference (I- Std. 95% Confidence
parasetamol parasetamol J) Error Sig. Interval
Upper Lower Upper Lower
Lower Bound Bound Bound Bound Bound
KONTROL PERLAKUAN 1 -22.7600(*) 10.0288 .042 -44.611 -.909
PERLAKUAN 2 -30.7800(*) 10.0288 .010 -52.631 -8.929
PERLAKUAN 1 KONTROL 22.7600(*) 10.0288 .042 .909 44.611
PERLAKUAN 2 -8.0200 10.0288 .439 -29.871 13.831
PERLAKUAN 2 KONTROL 30.7800(*) 10.0288 .010 8.929 52.631
PERLAKUAN 1 8.0200 10.0288 .439 -13.831 29.871
* The mean difference is significant at the .05 level.

LAMPIRAN 4. DOKUMENTASI
49
50
 51

LAMPIRAN 5. DAFTAR RIWAYAT HIDUP

Identitas
Nama : Indra Kusuma
NIM : G2A009128
Tempat, Tanggal lahir : Rembang, 27 November 1991
Jenis Kelamin : Laki-laki
Alamat : Ds. Soditan RT : 03/ II Lasem Kab. Rembang
Nomor Telepon : (0295) 531306
Nomor HP : 08811080222
e-mail : dr.iin.kusuma@gmail.com

Riwayat Pendidikan Formal

1. SD : MI-ANNASHRIYAH Lulus tahun : 2003

2. SMP : SMP N 1 LASEM Lulus tahun : 2006
3. SMA : SMA N 2 REMBANG Lulus tahun : 2009
4. FK UNDIP : Masuk tahun : 2009

Keanggotaan Organisasi

1. Ketua Jaringan Mahasiswa Kesehatan Indonesia Tahun 2011 s/d 2012

2. Wakil Ketua Medical Creative Arts Tahun 2010 s/d 2012
3. Staff Bidang Ekonomi Usaha dan Investasi Tahun 2010 s/d 2011